WHO: Millions of Children Hospitalized Due to RSV
According to estimates by the World Health Organization (WHO), approximately 3.6 million children worldwide require hospitalization each year due to respiratory syncytial virus (RSV). Tragically, for 100,000 of those affected, the infection can be fatal. Research by Prof. Thomas Pietschmann, Director of the Institute of Experimental Virology at TWINCORE in Hanover, indicates that the mechanisms by which RSV damages epithelial cells in the airways—and why the immune response struggles to control it—have remained poorly understood.
Cell Culture Models Reveal Changes in Individual Cells
To investigate this issue, researchers employed a specialized cell culture model using airway cells from human donors, typically patients receiving lung transplants. Prof. Bettina Wiegmann from the Medical University of Hanover explains that in the lab, these cells grow into a lung-like ciliated epithelium, complete with cilia and mucus production. After infecting the tissue culture with RSV, they analyzed gene activity in each individual cell through RNA sequencing. This revealed the regulation of thousands of genes in infected cells compared to their non-infected counterparts, as noted by Prof. Emmanuel Saliba from the Helmholtz Institute for RNA-based Infection Research.
RSV Suppresses Important Cellular Defense Mechanisms
Dr. Sibylle Haid, a researcher at Pietschmann’s institute, highlights a critical finding: only a small fraction of infected cells recognize that they have been infected. This failure likely arises from the insufficiency of certain lung cells to produce adequate amounts of virus detectors, which, in turn, means that these cells cannot generate messenger substances quickly enough to protect themselves and neighboring cells. A pivotal immune messenger is interferon, known for its direct antiviral properties and activation of interferon-stimulated genes (ISGs), which are essential for antiviral defense.
RSV Disrupts Cilia Formation in the Airways
Even treatment with interferon does not completely eliminate the virus, according to Dr. Haid. However, the research team found an exception: the antiviral transcription factor IRF1 is not suppressed by RSV. Remarkably, they demonstrated that artificially activating this factor can help reduce RSV infection, at least in simplified laboratory models.
Additionally, the researchers discovered a potential explanation for the cellular damage caused by RSV. Genes governing cilia formation were found to be inhibited in infected epithelial cells. The disruption of this vital function leads to the hallmark symptoms of RSV infection, affecting the body’s ability to clear mucus and pathogens from the respiratory tract.
Conclusion: Understanding RSV’s Mechanism
Understanding how RSV operates on a cellular level not only sheds light on its pathogenicity but also opens avenues for potential treatments and vaccine development. Targeting the immune response and enhancing the activity of specific antiviral factors like IRF1 may empower the body to better fend off RSV infections, reducing hospitalization rates and preventing severe outcomes for young patients.
These insights are crucial as the fight against RSV continues, emphasizing the need for ongoing research in this area to safeguard children’s health globally.
Literature
- Berg K et al. (2026) Respiratory syncytial viral load drives ciliated cell dedifferentiation and suppresses antiviral immunity, Science Advances, DOI: 10.1126/sciadv.aed4499
Keywords
Respiratory Syncytial Virus Infections (RSV)
